Home > Insider Trading > Pds Biotechnology Corp > Profile

Pds Biotechnology Corp (PDSB)

Market is closed

Sector: Pharmaceutical Preparations

Related Insiders

Gene Gregory Freitag, , 2025-03-03
C. Stephen Glover, , 2025-03-03
Richard Sykes, , 2024-06-25

Gene Gregory Freitag, , 2025-03-03
C. Stephen Glover, , 2025-03-03
Richard Sykes, , 2024-06-25
Ilian Iliev, , 2024-06-25
W Otis Brawley, , 2024-06-25
Kamil Ali-Jackson, , 2024-06-25
Stephan Toutain, Chief Operations Officer, 2024-05-02
V. Kirk Shepard, Chief Medical Officer, 2024-01-23
Lars Boesgaard, Chief Financial Officer, 2023-12-04
D. Spencer Brown, Senior Vp, General Counsel, 2023-01-06
C Matthew Hill, Chief Financial Officer, 2023-01-06
Gregory Conn, Chief Scientific Officer, 2023-01-06
Frank Bedu-Addo, President/Ceo, 2023-01-06
Lauren Wood, Chief Medical Officer, 2023-01-06
Janetta Trochimiuk, Principal Accounting Officer, 2021-10-12
Seth Voorhees Van, Chief Financial Officer, 2021-06-17
N. Michael King, Interim Cfo, 2020-12-09
W Delyle Bloomquist, , 2020-06-25
Andrew Saik, Chief Financial Officer, 2020-02-19
J James Loughlin, Director, 2019-07-01
Loch R. Macdonald, Director, 2019-03-18
J. Robert Spiegel, Director, 2019-03-18
Liam Ratcliffe, Director, 2019-03-18
Bradford W Middlekauff, Senior Vp, Gc And Secretary, 2019-03-18
A Brian Leuthner, President And Ceo, 2019-03-18
Isaac Blech, Director, 2019-03-18
A Rosemary Crane, Director, 2019-03-18
J Sol Barer, Director, 2019-03-18
Alyssa Wyant, Svp Regulatory Affairs, 2019-01-03
Ii N Albert Marchio, Chief Accounting & Adm Officer, 2018-12-31
J Herbert Faleck, Chief Medical Officer, 2018-12-31
G Kurt Conti, Director, 2018-03-30
Daniel Brennan, Chief Operating Officer, 2018-03-05
James Healy, Director, 2017-06-21
Alpaslan Yaman, V.p., Technical Ops. & Mfg., 2017-03-15
J. Andrew Einhorn, Chief Financial Officer, 2017-03-13
New Leaf Venture Partners, L.l.c., Director, 2016-06-24
New Leaf Venture Management Iii, L.l.c., Director, 2016-06-24
New Leaf Venture Associates Iii, L.p., Director, 2016-06-24
New Leaf Ventures Iii, L.p., Director, 2016-06-24
Renu Vaish, V.p., Global Reg. Affairs, 2016-06-20
D Anders Hove, Director, 2015-10-08

Show All Insiders (42)

Hedge Fund Popularity

Display

Display Share Price

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on February 14, 2025, 5:04 pm based on SEC 13F filings Last update: February 14, 2025, 5:04 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Citadel Investment Group Ken Griffin	220,215	$358,950	+92%	0%
2.	Millennium Management Israel Englander	126,416	$206,058	-47%	0%
3.	Renaissance Technologies Jim Simons	100,000	$163,000	+332%	0%
4.	Marshall Wace LLP Paul Marshall And Ian Wace	39,024	$63,609	+39%	0%
5.	Sherbrooke Park Advisers Kun Gao	14,026	$22,862		0%

Insider Trading: Purchases See All

Insider	Price	Amount	Remaining Holdings	Date	Form 4
Freitag	$1.66	15,060	61,213	2025-02-28	Filing
Glover	$1.66	15,061	78,851	2025-02-28	Filing
Hill	$9.00	100	4,075	2021-12-13	Filing
Hill	$9.00	100	3,975	2021-12-13	Filing
Hill	$8.90	400	3,875	2021-12-13	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Macdonald	$16.41	2,500	Officer, Director	570,602	2018-03-22	Filing
Macdonald	$16.52	2,500	Officer, Director	573,102	2018-03-21	Filing
Macdonald	$16.47	5,000	Officer, Director	575,602	2018-03-20	Filing
Macdonald	$16.66	2,500	Officer, Director	580,602	2018-03-19	Filing
Leuthner	$15.08	2,500	Officer, Director	70,236	2018-03-02	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Inspirion Wealth Advisors, Llc	75,382	$89,705	0.01%
2.	Sandbox Financial Partners, Llc	12,666	$15,073	0.01%
3.	Burns J W & Co Inc	10,300	$12,257	0%

News See All

Click here to See All News